Ampliphi Biosciences Corp (NYSEAMERICAN:APHB – Get Free Report)’s stock price traded up 2% during trading on Monday . The stock traded as high as $2.12 and last traded at $2.08. 5,987 shares changed hands during mid-day trading, a decline of 99% from the average session volume of 842,200 shares. The stock had previously closed at $2.04.
Ampliphi Biosciences Trading Down 2.9 %
About Ampliphi Biosciences
AmpliPhi Biosciences Corporation, a biotechnology company, focuses on the development of therapies for antibiotic-resistant infections using bacteriophage-based technology. The company is involved in developing AB-SA01 for the treatment of staphylococcus aureus (S. aureus) infections; and AB-PA01 for the treatment of pseudomonas aeruginosa (P.
Recommended Stories
- Five stocks we like better than Ampliphi Biosciences
- P/E Ratio Calculation: How to Assess Stocks
- 3 Reasons Micron Stock Is Deeply Undervalued Right Now
- Stock Average Calculator
- Inflation Persists, But So Do Stock Opportunities: Rally On
- Consumer Discretionary Stocks Explained
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
Receive News & Ratings for Ampliphi Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampliphi Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
